Retrospective Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Mar 21, 2018; 24(11): 1250-1258
Published online Mar 21, 2018. doi: 10.3748/wjg.v24.i11.1250
Table 1 Demographic and clinical characteristics of remunerated blood donors
Blood donors, n = 363Single plasma donors, n = 780Blood and plasma donors, n = 551P value
Age in yr56.8 ± 13.257.2 ± 11.357.1 ± 9.40.8821
≥ 40, < 5056 (15.4)83 (10.6)68 (12.3)0.07
≥ 50, < 60203 (55.9)501 (64.2)336 (61.0)
≥ 60104 (28.7)196 (25.1)147 (26.7)
Sex
Male123 (33.92)315 (36.5)211 (38.3)0.1092
Female240 (66.1)465 (63.5)340 (61.5)
BMI25.52 ± 4.3225.36 ± 4.1125.45 ± 3.220.3531
< 25178 (49)395 (50.6)294 (53.4)0.1672
≥ 25, < 28130 (35.8)284 (36.4)169 (30.7)
≥ 2855 (15.2)101 (12.9)88 (16)
PLT as × 109/L207.3 ± 64.8161.8 ± 55.4176.3 ± 63.1< 0.0011
ALB in g/L42.3 ± 3.541.4 ± 4.743.3 ± 4.50.5131
ALT in U/L27.4 ± 6.563.2 ± 18.752.6 ± 15.4< 0.0011
AST in U/L23.5 ± 7.455.4 ± 12.944.5 ± 22.6< 0.0011
Anti-HCV
Positive12 (3.3)534 (68.5)324 (58.8)< 0.0012
Negative351 (96.7)246 (31.5)227 (41.29)
HBsAg
Positive2 (0.6)3 (0.4)1 (0.2)0.6433
Negative361 (99.4)777 (99.6)550 (99.8)
LSM in kPa5.56 ± 2.647.37 ± 3.626.54 ± 3.54< 0.0011
≥ 92 (0.6)224 (28.7)122 (22.1)< 0.0012
< 9, ≥ 620 (5.5)313 (40.1)287 (52.1)
< 6341 (93.9)243 (31.2)142 (25.8)
Blood donated frequency times
≥ 10212 (58.4)245 (31.4)187 (33.9)< 0.0012
< 10, ≥ 5120 (33.1)352 (45.1)202 (36.7)
< 531 (8.5)183 (23.5)162 (29.4)
Interval time from last donated blood to survey in yr27.56 ± 2.1127.65 ± 3.0227.84 ± 2.540.4531
Refused donated by elevated ALT
Yes37 (10.2)317 (40.6)195 (35.4)< 0.0012
No326 (89.8)463 (59.4)356 (64.6)
Table 2 Demographic and clinical characteristics of hepatitis C virus in remunerated blood donors and multiple logistic regression analysis of factors associated with hepatitis C virus
CHC, n = 592No CHC, n = 278P valueMultivariate4
OR95%CIWaldP value
Age in yr55.4 ± 13.258.5 ± 9.4< 0.00111.6420.426-11.1643.0120.013
≥ 40, < 50121 (20.4)35 (12.6)0.00321
≥ 50, < 60356 (60.1)168 (60.4)3.5420.521-13.2541.5340.435
≥ 60115 (19.4)75 (27.0)11.2260.065-137.535.3220.004
Sex
Male277 (46.8)111 (39.9)0.05821
Female315 (53.2)167 (60.1)0.2330.054-6.6341.0040.364
Alcohol consumption0.5320.147-1.6470.8530.547
Never441 (74.5)175 (62.9)0.00220.4360.124-1.0061.0750.443
Occasional95 (16.0)68 (24.5)0.8760.857-1.3541.4460.374
Often56 (9.5)35 (12.6)1.2310.843-1.5560.6670.432
BMI24.12 ± 2.3225.45 ± 3.22< 0.00110.8890.674-1.3270.8960.547
< 25278 (47.0)194 (69.8)< 0.00121.2160.536-1.6250.0340.646
≥ 25, < 28230 (38.9)69 (24.8)7.2330.054-66.631.5340.343
≥ 2884 (14.2)15 (5.4)4.3650.643-22.5341.5430.113
HOMA-IR1.53 ± 0.481.31 ± 0.52< 0.00111.0020.864-1.0070.9840.657
PLT as × 109/L164.3 ± 64.8196.3 ± 73.1< 0.00113.1121.475-121.15316.886< 0.001
ALB in g/L42.3 ± 3.543.3 ± 4.50.51310.5760.645-1.21470.5430.674
ALT in U/L67.4 ± 26.522.6 ± 15.4< 0.00113.2161.036-121.62525.034< 0.001
AST in U/L53.5 ± 17.424.5 ± 10.6< 0.00112.5780.937-76.35426.332< 0.001
SMA
Negative517 (87.3)262 (94.2)0.00221
Positive75 (12.7)16 (5.8)1.1460.545-1.6540.5430.653
ANA
Negative477 (80.6)244 (87.8)0.00921
Positive115 (19.4)34 (12.2)1.4230.587-1.0010.1230.886
IgG
Normal271 (45.8)261 (93.9)< 0.00121
Elevated321(54.2)17 (6.1)6.0010.957-12.3536.075< 0.001
LSM in kPa7.67 ± 4.434.12 ± 2.25< 0.00110.2330.054-6.6341.0040.364
< 6155 (26.2)241 (86.7)< 0.00121
< 9, ≥ 6211 (35.6)31 (11.2)0.5320.147-1.6470.8530.547
≥ 9226 (38.2)6 (2.2)2.4360.124-11.7767.075< 0.001
Blood donated frequency times8.67 ± 6.438.42 ± 6.250.10711.2330.874-1.1341.0320.832
< 5139 (23.5)62 (22.3)0.10121
< 10, ≥ 5252 (42.6)102 (36.7)0.9320.927-1.4331.0320.883
≥ 10201 (34.0)114 (41.0)0.2470.257-1.7541.0540.664
Refused donated by elevated ALT
No377 (63.7)148 (53.2)0.00331
Yes215 (36.3)130 (46.8)1.6681.061-3.1434.8040.027
Table 3 Demographic and clinical characteristics of cirrhosis by hepatitis C virus infection in remunerated blood donors and multiple logistic regression analysis of factors associated with cirrhosis
Cirrhosis by HCV, n = 161CHC, n = 431P valueMultivariate4
OR95%CIWaldP value
Age in yr58.4 ± 13.256.5 ± 9.4< 0.00112.1430.553-6.4534.5430.002
≥ 40, < 5041 (25.43)80 (18.6)0.03421
≥ 50, < 6082 (50.9)270 (62.6)2.4430.242-7.3451.4230.065
≥ 6038 (23.6)81 (18.8)3.2230.124-14.3443.1530.021
Sex
Male75 (46.6)202 (46.9)0.95121
Female86 (53.4)229 (53.1)1.2230.112-6.7650.6530.445
Alcohol consumption
Never97 (60.2)344 (79.8)< 0.00121
Occasional40 (24.8)55 (12.8)0.8790.647-2.6542.7530.152
Often24 (14.9)32 (7.4)1.0040.875-1.7443.0570.005
BMI24.12 ± 2.3225.45 ± 3.220.35310.6470.465-1.6324.1350.432
< 2578 (48.4)200 (46.4)0.10821
≥ 25, < 2868 (42.2)162 (37.6)1.2420.574-1.7350.5360.438
≥ 2815 (9.3)69 (16)0.6650.426-1.6450.4760.537
HOMA-IR1.53 ± 0.481.51 ± 0.520.5560.0230.772-1.4230.3650.221
PLT as × 109/L147.3 ± 55.7176.3 ± 84.2< 0.00111.3140.022-1.4633.6470.013
ALB in g/L42.3 ± 3.543.3 ± 4.50.51310.8640.707-1.3641.5570.675
ALT in U/L67.4 ± 26.562.6 ± 25.40.11311.6430.463-1.7550.6340.247
AST in U/L53.5 ± 27.454.5 ± 22.60.20111.4250.428-1.2540.5460.664
SMA
Negative144 (89.4)373 (86.5)0.34621
Positive17 (10.6)58 (13.5)0.5260.537-1.8431.0340.536
ANA
Negative130 (80.7)347 (80.5)0.94511
Positive31 (19.3)84 (19.5)2.1230.132-5.5630.8430.246
IgG
Normal60 (37.3)205 (47.6)0.02521
Elevated101 (62.7)226 (52.4)1.3520.663-12.2673.5370.012
HCV RNA in LgIU/mL7.12 ± 2.436.73 ± 2.5330.06710.6570.536-1.5230.8630.536
≥ 3, < 522 (13.7)51 (11.8)0.54621
≥ 5139 (86.3)380 (88.2)1.3250.972-1.4450.1430.782
Genotype
I152 (94.4)390 (90.5)0.31021
II8 (5.0)37 (8.6)0.7531.003-1.6640.6230.242
III1 (0.6)4 (0.9)1.8621.182-1.6350.8450.118
Blood donated frequency times8.67 ± 5.438.42 ± 6.250.10711.5360.874-2.1540.9230.101
< 536 (22.4)103 (23.9)0.69821
< 10, ≥ 566 (41.0)186 (43.2)0.3540.274-1.2030.9910.783
≥ 1059 (36.6)142 (32.9)1.0240.154-2.1630.3320.224
Refused donated by elevated ALT
No94 (58.4)243 (56.4)0.66121
Yes67 (41.6)188 (43.6)0.0120.037-1.0020.6820.563